États-Unis · Bourse & Finance · Investor's Business Daily

Teva, Already Up 26% This Year, Surges Again On First-Of-Its-Kind Approval

Publié par Investor's Business Daily · États-Unis il y a 1 j

Teva stock surged Friday after the FDA approved its schizophrenia drug, a once-monthly injectable treatment for the disease.

Lire l'article complet sur Investor's Business Daily Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.investors.com)

À lire aussi

Business Insider

I moved my family from Australia to New York City 12 years ago. It's led to some very expensive regrets.

China passenger vehicle retail market slumps 24% in September

CFTC Draws the Line Between Prediction Markets and Gambling in New Rules

Petra Power looks to modernize energy for data centers and defense vehicles

Kasai, Klarity and 8 other baby names surging in America

JPMorgan makes bullish call in fixed income space, suggests it's a once in a generation opportunity